As sale of Phoenix stalls, conglomerate weighing plan to spin off non-energy businesses into separate company.
Tel Aviv Stock Exchange
Both companies are profitable, generate returns on equity of 10% to 15% a year, and would likely distribute dividends. This is the kind of thing that investors would happily welcome.
Knesset panel approves bill for restructuring stock exchange | Novolog meets strong demand in IPO | Tel Aviv shares decline for first time in four sessions
Business in Brief: Teva Wins Copaxone Respite After Momenta Says Its Generic Probably Won’t Launch in Q1
Delek affiliate Ithaca Energy begins North Sea production | MySize allocates shares at steep discount to unnamed investor | Tel Aviv shares end higher in light trading
TA-25 and other TASE stalwarts give way to six new market measures.
IC Power begins IPO at $1.4 billion valuation | Kornit moves ahead with secondary offering | Companies fail to boost women directors | Africa Israel unit sells 4hotels for NIS 524m
Huge debts and a loss of faith by investors – how Israeli drugmaker’s dreams turned into a nightmare.
Exits are just part of the picture, and their shrinking number could derive from an uptick in other criteria that reflect growth and maturity in the high-tech industry.
Drilling, Avner seek to boost bond issue | Strauss buys German coffee company | Weak Tel Aviv market kept aloft by Teva, Israel Corp., Israel Chemcials
Spacecom to buy Boeing satellite to replace ill-fated Amos 6 | Cornerstone set to become TASE’s 19th U.S. property company | Tel Aviv shares lose ground amid sagging U.S., European markets